Morgan Stanley’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-20,310
Closed -$21K 6956
2019
Q1
$21K Buy
20,310
+14,446
+246% +$14.9K ﹤0.01% 6008
2018
Q4
$4K Sell
5,864
-7,058
-55% -$4.81K ﹤0.01% 6361
2018
Q3
$28K Buy
12,922
+590
+5% +$1.28K ﹤0.01% 6053
2018
Q2
$29K Buy
12,332
+5,365
+77% +$12.6K ﹤0.01% 6062
2018
Q1
$22K Buy
6,967
+850
+14% +$2.68K ﹤0.01% 6111
2017
Q4
$25K Sell
6,117
-29,938
-83% -$122K ﹤0.01% 6024
2017
Q3
$163K Buy
36,055
+7,476
+26% +$33.8K ﹤0.01% 5435
2017
Q2
$95K Sell
28,579
-24,268
-46% -$80.7K ﹤0.01% 5657
2017
Q1
$487K Sell
52,847
-56,096
-51% -$517K ﹤0.01% 4854
2016
Q4
$840K Buy
108,943
+20,427
+23% +$158K ﹤0.01% 4599
2016
Q3
$1.01M Buy
88,516
+63,302
+251% +$723K ﹤0.01% 4028
2016
Q2
$311K Buy
25,214
+4,074
+19% +$50.3K ﹤0.01% 4710
2016
Q1
$214K Sell
21,140
-129,122
-86% -$1.31M ﹤0.01% 4936
2015
Q4
$3.39M Buy
150,262
+40,178
+36% +$906K ﹤0.01% 3041
2015
Q3
$1.83M Buy
110,084
+6,139
+6% +$102K ﹤0.01% 3597
2015
Q2
$2.34M Buy
103,945
+1,262
+1% +$28.4K ﹤0.01% 3484
2015
Q1
$2.65M Buy
102,683
+8,874
+9% +$229K ﹤0.01% 3324
2014
Q4
$2.04M Buy
93,809
+21,334
+29% +$464K ﹤0.01% 3545
2014
Q3
$1.37M Buy
72,475
+67,514
+1,361% +$1.28M ﹤0.01% 3761
2014
Q2
$116K Sell
4,961
-34,761
-88% -$813K ﹤0.01% 5432
2014
Q1
$1.34M Buy
39,722
+27,978
+238% +$942K ﹤0.01% 3756
2013
Q4
$347K Buy
11,744
+1,503
+15% +$44.4K ﹤0.01% 4721
2013
Q3
$157K Buy
+10,241
New +$157K ﹤0.01% 4975